KFSH Advances Preventive Genomics from Genetic Risk Detection to Family-Centered Action

NY, UNITED STATES, September 8, 2026 /EINPresswire.com/ -- King Faisal Specialist Hospital and Research Centre (KFSH) is helping families act before serious inherited conditions are passed to the next generation through the Middle East's largest Pre-implantation Genetic Testing program by annual case volume. In a region where inherited disorders remain a significant health challenge, the program brings embryo testing, genomic analysis and genetic counselling into one preventive pathway for families at risk.

Pre-implantation genetic testing is established in specialist IVF care internationally, but access and uptake vary widely between health systems. KFSH's program gives families in Saudi Arabia and the wider region access to advanced testing before pregnancy, while connecting premarital screening, prenatal diagnostics and precision medicine services across later stages of care.

At the center of this approach is the use of whole-genome and next-generation sequencing technologies to detect variants associated with serious inherited conditions. Genetic counselling before and after testing helps families understand the medical significance of the results, evaluate available options and make decisions informed by their individual circumstances.

KFSH's Pre-implantation Genetic Testing program applies this preventive model before pregnancy by analyzing embryos for disease-causing mutations prior to implantation. Since its launch in 2001, the program has served thousands of families and has grown into the largest of its kind in the Middle East by annual case volume, performing nearly half the number of comparable procedures conducted across Europe combined.

The program demonstrates how preventive genomics can produce value beyond individual diagnosis. Earlier identification of inherited risks can reduce repeated diagnostic procedures, prevent avoidable complications and help healthcare systems direct resources toward intervention before complex disease develops. KFSH has previously estimated that preventing the lifelong medical burden associated with a serious inherited disorder could save approximately SAR 1 million annually in treatment and care costs.

Taken together, these services support a transition from reactive treatment to predictive, prevention-led healthcare at both family and population levels. KFSH will address this theme during the C3 US NYC Davos of Healthcare™ Summit 2026, to be held on September 14 in New York City.

This approach reflects KFSH's broader commitment to making genomic information clinically actionable, ethically responsible and accessible across the continuum of care, positioning prevention as one of the most consequential applications of precision medicine.

King Faisal Specialist Hospital and Research Centre has been ranked first in the Middle East and Africa and 12th globally among the world's top 250 academic medical centers for 2026. It was also recognized as the most valuable healthcare brand in the Kingdom and the Middle East for 2026, according to Brand Finance, and listed by Newsweek among the World's Best Hospitals, World's Best Smart Hospitals, and World's Best Specialized Hospitals for 2026.

KFSH
Riyadh
email us here